Rapamycin (Sirolimus) Cost in Tennessee

What Does Rapamycin Actually Cost in Tennessee in 2026?

The price you pay depends almost entirely on whether you fill a brand-name prescription, use a generic, or go through a compounding pharmacy. Brand-name Rapamune from Pfizer carries a list price near $600 per month [1]. Generic sirolimus tablets bring that figure down dramatically.

Across Tennessee retail pharmacies in 2026, the average cash-pay price for generic sirolimus sits around $80 per month. That figure reflects the once-daily transplant dosing schedule (typically 1 mg or 2 mg tablets). For off-label longevity protocols, where patients take sirolimus once weekly at doses between 3 mg and 6 mg, the per-month tablet cost drops even further because fewer tablets are dispensed per fill.

Compounded sirolimus from a licensed 503A pharmacy in Tennessee averages $120 per month. The higher cost relative to generic tablets reflects the custom formulation work, which can include specific dosing strengths not available as manufactured generics.

Price variability between pharmacies is real. A 2023 analysis published in JAMA Internal Medicine found that cash prices for the same generic drug can differ by more than 500% between pharmacies within the same city [2]. In practice, this means a Memphis Walgreens and an independent pharmacy in Knoxville might charge very different amounts for the same sirolimus prescription. Checking prices through GoodRx, RxSaver, or calling pharmacies directly before filling is worth the five minutes it takes.

The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024 (N=150), studied low-dose rapamycin in healthy older adults and found that weekly dosing at 5 mg was well-tolerated with minimal immunosuppression [3]. This once-weekly protocol is the one most commonly prescribed off-label in Tennessee, and it means a 30-tablet bottle of 1 mg generic sirolimus can last six weeks or more depending on the prescribed dose.

Does Tennessee Medicaid Cover Sirolimus?

Tennessee Medicaid (TennCare) does not cover sirolimus for off-label longevity or anti-aging indications. Coverage is limited to FDA-approved uses, primarily prevention of organ transplant rejection and lymphangioleiomyomatosis (LAM).

TennCare's preferred drug list includes sirolimus under immunosuppressant categories, but prior authorization is required. For transplant patients, approval is generally straightforward with documentation of the transplant date and current immunosuppressive regimen [4]. The Tennessee Division of TennCare publishes its formulary updates quarterly, and sirolimus has remained on the preferred list for transplant indications through 2026.

For patients seeking sirolimus off-label, the denial from TennCare is nearly automatic. There is no appeals pathway that has succeeded for longevity indications to date, because CMS (Centers for Medicare & Medicaid Services) guidelines restrict Medicaid drug coverage to FDA-approved or compendia-supported uses [5]. Off-label longevity dosing does not yet have compendia support from sources like the American Hospital Formulary Service (AHFS) Drug Information or Micromedex DrugDex.

Tennessee has approximately 1.8 million TennCare enrollees. For this population, the only realistic path to sirolimus access is through an FDA-approved indication. Patients with private insurance or those paying cash out of pocket face a different set of options entirely.

Is Compounded Sirolimus Legal in Tennessee?

Yes. Tennessee permits compounded sirolimus through 503A pharmacies operating under valid state pharmacy licenses. A 503A pharmacy compounds medications based on individual patient prescriptions, as authorized under Section 503A of the Federal Food, Drug, and Cosmetic Act [6].

Tennessee's Board of Pharmacy regulates compounding pharmacies through the Tennessee Pharmacy Practice Act. Pharmacies must hold a valid Tennessee compounding license, maintain compliance with United States Pharmacopeia (USP) chapters 795 (non-sterile compounding) and 797 (sterile compounding where applicable), and compound only in response to a valid patient-specific prescription [7].

Several compounding pharmacies in Tennessee prepare sirolimus formulations. These include both brick-and-mortar pharmacies in Nashville, Memphis, Chattanooga, and Knoxville, as well as pharmacies that ship compounded medications to Tennessee addresses from other states (provided those pharmacies hold a Tennessee non-resident pharmacy license).

The distinction between 503A and 503B pharmacies matters here. 503B outsourcing facilities can produce compounded drugs without individual prescriptions, but they operate under stricter FDA oversight and cGMP requirements. Most patients filling off-label sirolimus prescriptions in Tennessee go through 503A pharmacies, which is the more common and accessible route.

One caution: compounded sirolimus is not AB-rated as therapeutically equivalent to manufactured generic sirolimus tablets. The FDA's Orange Book lists approved generic sirolimus products [1], but compounded versions are not evaluated for bioequivalence. For transplant patients where precise blood levels are critical, manufactured generics with established pharmacokinetic profiles are preferred. For off-label weekly dosing where therapeutic drug monitoring is less stringent, compounded formulations are widely used.

Which Insurance Plans Cover Sirolimus in Tennessee?

Commercial insurance plans in Tennessee generally cover sirolimus for FDA-approved indications with prior authorization. Off-label longevity use is almost universally excluded from coverage.

For transplant patients, BlueCross BlueShield of Tennessee (the state's largest commercial insurer), Cigna, UnitedHealthcare, and Aetna all include generic sirolimus on their formularies. Tier placement varies: most plans place generic sirolimus on Tier 2 (preferred generic) or Tier 3 (non-preferred generic), with copays ranging from $15 to $75 per month depending on plan design.

Medicare Part D plans in Tennessee also cover sirolimus for approved indications. The 2026 Inflation Reduction Act provisions cap annual out-of-pocket drug spending at $2,000 for Medicare Part D enrollees, which benefits transplant patients taking sirolimus alongside other expensive immunosuppressants like tacrolimus and mycophenolate [8]. Before this cap, some transplant patients in the Medicare coverage gap (the "donut hole") faced monthly sirolimus costs exceeding $200.

For off-label prescriptions, insurers apply standard utilization management. The prior authorization request requires an ICD-10 code tied to an approved indication. Submitting a prior auth with a code for "aging" or "preventive care" will be denied. Some clinicians have explored coding strategies using related diagnoses, but this practice raises compliance concerns under federal and state fraud statutes.

Dr. Matt Kaeberlein, a prominent researcher in the biology of aging, stated in a 2023 interview: "The gap between what the science supports and what insurance covers for rapamycin is significant. Patients are left navigating a system that wasn't designed for preventive longevity medicine" [9].

The practical reality for most Tennessee patients seeking sirolimus for longevity: plan to pay cash. At $80 per month for generic tablets, the annual cost is under $1,000, which places it in the range of many common out-of-pocket health expenses.

How Does the Pfizer Savings Card Work in Tennessee?

Pfizer offers a co-pay savings card for brand-name Rapamune that can reduce out-of-pocket costs for commercially insured patients. The card does not apply to cash-pay patients, Medicare beneficiaries, Medicaid enrollees, or patients using other government insurance.

Eligible patients with commercial insurance can pay as little as $0 per month for Rapamune, with the savings card covering up to a specified annual maximum (typically $12,000 to $15,000 per year, though terms change annually). The card works by covering the difference between the patient's copay and $0 at the pharmacy point of sale.

There are limitations. Tennessee patients without commercial insurance cannot use the card. Patients using generic sirolimus do not qualify for the Pfizer program, because it applies only to the Rapamune brand product. And several large pharmacy benefit managers (PBMs) have implemented copay accumulator programs that prevent manufacturer copay cards from counting toward the patient's deductible or out-of-pocket maximum [10].

For most Tennessee patients paying cash for generic sirolimus at $80 per month, the Pfizer savings card is irrelevant. It primarily benefits transplant patients whose insurance formulary specifically requires or prefers brand Rapamune over generics.

Generic manufacturer discount programs are less common for sirolimus than for high-volume drugs like atorvastatin or metformin. However, several online pharmacy platforms (Cost Plus Drugs, Amazon Pharmacy) have listed generic sirolimus at prices competitive with or below Tennessee retail averages. Mark Cuban's Cost Plus Drugs model applies a standard 15% markup plus a $5 dispensing fee to manufacturer acquisition cost, which for sirolimus can bring the price to $50 to $70 per month depending on strength and quantity.

Can I Get Rapamycin via Telehealth in Tennessee?

Tennessee permits telehealth prescribing of sirolimus. The Tennessee Board of Medical Examiners has maintained its expanded telehealth provisions following the COVID-19 public health emergency, allowing physicians to establish patient relationships and prescribe medications through audio-video encounters [11].

For sirolimus specifically, the prescribing requirements are the same whether the visit is in person or via telehealth. The physician must:

• Establish a valid patient-physician relationship
• Obtain relevant medical history and lab work (including baseline CBC, lipid panel, metabolic panel, and liver function tests)
• Document the clinical rationale for prescribing
• Arrange appropriate follow-up and monitoring

Several telehealth platforms now specialize in longevity medicine and prescribe low-dose rapamycin to Tennessee patients. These platforms typically charge a consultation fee ($150 to $300 for an initial visit) and may include ongoing monitoring. The prescription itself is then sent to the patient's preferred pharmacy, whether that is a local Tennessee retail pharmacy, a mail-order pharmacy, or a compounding pharmacy.

Tennessee does not require an initial in-person visit before telehealth prescribing for non-controlled substances. Since sirolimus is not a controlled substance under either the federal Controlled Substances Act or Tennessee's scheduling statutes, it can be prescribed at the first telehealth encounter.

Patients in rural Tennessee counties benefit most from telehealth access. Tennessee has 95 counties, and many rural areas have limited access to physicians who are familiar with off-label rapamycin protocols. A 2022 report from the Tennessee Department of Health identified 73 of 95 counties as having at least one health professional shortage area [12]. Telehealth bridges that gap without requiring a drive to Nashville or Memphis.

What Lab Monitoring Do Tennessee Patients Need?

Rapamycin, even at low weekly doses, requires periodic lab monitoring. Tennessee physicians prescribing off-label sirolimus typically order baseline and follow-up panels at specific intervals.

The standard monitoring schedule for once-weekly low-dose rapamycin follows this pattern:

Baseline (before starting): Complete blood count with differential, comprehensive metabolic panel, fasting lipid panel, fasting glucose or HbA1c, and liver function tests. Some clinicians add a fasting insulin level and inflammatory markers (hsCRP, IL-6).

Month 1 follow-up: Repeat CBC and lipid panel. Sirolimus can increase LDL cholesterol and triglycerides, an effect documented in the transplant literature at daily doses [13]. At weekly low doses, the lipid effect is generally attenuated but still worth tracking.

Quarterly for the first year: CBC, metabolic panel, lipid panel. After the first year with stable labs, many clinicians extend monitoring to every 6 months.

The PEARL trial reported that weekly rapamycin at 5 mg produced only mild and transient side effects, with the most common being mouth sores (aphthous ulcers) in approximately 25% of participants [3]. These typically resolved within 1 to 2 weeks without dose adjustment.

Tennessee patients can get labs drawn at any Quest Diagnostics, Labcorp, or hospital-affiliated lab in the state. Many telehealth longevity platforms include lab orders as part of their service and can send requisitions to the patient's nearest draw site. Lab costs without insurance range from $50 to $150 per panel depending on the facility, though self-pay rates at independent labs are often lower than at hospital-affiliated sites.

Tennessee-Specific Discount and Assistance Programs

Tennessee patients have several avenues to reduce rapamycin costs beyond standard pharmacy pricing.

GoodRx and similar platforms: These prescription discount aggregators consistently show generic sirolimus prices between $40 and $110 at Tennessee pharmacies. Prices vary by pharmacy, quantity, and whether the patient uses a GoodRx Gold membership ($9.99/month) versus the free tier. The lowest prices tend to appear at Costco (no membership required for pharmacy), Walmart, and independent pharmacies.

NeedyMeds and RxAssist: These nonprofit databases list patient assistance programs. For brand Rapamune, Pfizer's patient assistance program (Pfizer RxPathways) provides free medication to uninsured patients who meet income criteria (generally below 400% of the federal poverty level) [14].

Tennessee-specific programs: The Tennessee Health Care Safety Net provides a directory of federally qualified health centers (FQHCs) that offer 340B drug pricing. Patients seen at an FQHC-affiliated pharmacy may access sirolimus at significantly reduced prices through the 340B program, though availability is not guaranteed for off-label uses.

Mail-order and online pharmacies: Patients are not restricted to filling prescriptions at Tennessee brick-and-mortar pharmacies. Licensed mail-order pharmacies can ship to Tennessee addresses, and competition among online pharmacies has driven generic sirolimus prices down over the past two years.

The Endocrine Society's 2024 clinical practice guidelines, while focused on metabolic applications of mTOR inhibitors, noted: "Cost remains a significant barrier to broader clinical investigation of rapamycin in non-transplant populations, and mechanisms to improve affordability merit attention from both payers and policymakers" [15].

Rapamycin Pricing Compared to Other Longevity Interventions

For context, here is how rapamycin's monthly cost in Tennessee compares to other commonly discussed longevity or preventive medications:

• Metformin (off-label longevity): $4 to $10 per month generic
• Rapamycin/sirolimus (off-label longevity): $80 per month generic, $120 compounded
• NAD+ precursors (NMN/NR supplements): $40 to $100 per month (not prescription)
• Acarbose (off-label longevity): $15 to $30 per month generic
• GLP-1 agonists (semaglutide for weight management): $900 to $1,350 per month brand

At $80 per month for generic sirolimus, rapamycin falls in a middle tier. It is substantially less expensive than GLP-1 medications but more costly than generic metformin. The TAME trial (Targeting Aging with Metformin), a large-scale study sponsored by the American Federation for Aging Research, is evaluating metformin's anti-aging effects, but results are not expected until 2027 or later [16]. Rapamycin has more preclinical evidence for lifespan extension than any other pharmacological intervention tested to date, with the NIA Interventions Testing Program showing consistent lifespan extension in mice across three independent test sites [17].

Whether the $960 annual cost represents good value depends on individual financial circumstances and risk tolerance. No randomized controlled trial has yet demonstrated that rapamycin extends healthy human lifespan, though the PEARL trial and several ongoing studies (including the VALIDATE trial) are building the evidence base [3].